Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo the treatment for about 12-16 weeks.

Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all ...

The global IT services company — which employs about 799,000 staffers — will start to “sunset” its diversity policies, ...

CEO Julie Sweet said the company would end its employee diversity representation goals and put “a greater focus on inclusion and a sense of belonging for all,” in an internal memo.

Consultants said to be "in a tailspin" over the ethnic diversity of the stock photos in their PowerPoints. Maybe.

Accenture is discontinuing its diversity, equity, and inclusion (DEI) goals in response to shifts in the US political ...

Accenture CEO Julie Sweet advises staff of a global evolution as the consulting giant abandons DEI programs in response to ...

Accenture Plc, the professional services firm with nearly 800,000 employees around the world, is abandoning its diversity ...

However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...